Literature DB >> 29446693

Hyperparathyroidism Mimicking Metastatic Bone Disease: A Case Report and Review of Literature.

Monica Gupta1, Lalita Singhal2, Akshay Kumar3.   

Abstract

Multiple osteolytic lesions are usually associated with metastatic involvement of the bone; however, metabolic bone diseases should also be included in the differential diagnosis. In this study, we describe a case of primary hyperparathyroidism (PHPT) with multiple osteolytic lesions that was diagnosed initially as having metastatic bone involvement. The laboratory results showed hypercalcemia and raised alkaline phosphatase along with fibrosis in the bone marrow biopsy with no increase in tumor markers and normal serum protein electrophoresis. The parathyroid hormone levels were high, which pointed toward a diagnosis of PHPT. Sestamibi scan revealed uptake at the level of the left inferior pole of the thyroid gland, which was suggestive of parathyroid adenoma. The possibility of hyperparathyroidism should be kept in mind when a patient presents with multiple osteolytic lesions and hypercalcemia.

Entities:  

Keywords:  hypercalcemia; hyperparathyroidism; lytic bone lesions

Mesh:

Year:  2018        PMID: 29446693     DOI: 10.1089/jayao.2017.0114

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN: 2156-5333            Impact factor:   2.223


  2 in total

1.  The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism.

Authors:  Mechteld C de Jong; K Jamal; S Morley; T Beale; T Chung; S Jawad; S Hurel; H Simpson; U Srirangalingam; S E Baldeweg; V Rozalén García; S Otero; M Shawky; T E Abdel-Aziz; T R Kurzawinski
Journal:  Hormones (Athens)       Date:  2020-05-13       Impact factor: 2.885

2.  Severe Primary Hyperparathyroidism Caused by Parathyroid Carcinoma in a 13-Year-Old Child; Novel Findings From HRpQCT.

Authors:  Nina Lenherr-Taube; Carol Kl Lam; Reza Vali; Amer Shammas; Paolo Campisi; Faisal Zawawi; Gino R Somers; Jennifer Stimec; Ozgur Mete; Andy Ko Wong; Etienne Sochett
Journal:  JBMR Plus       Date:  2020-01-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.